WHO ICTRP trial

Comparative assessment of the absorption of two generic formulations of…

ACTRN12614000267651 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12614000267651
Public title Comparative assessment of the absorption of two generic formulations of doxycycline delayed release capsule against the innovator doxycycline delayed release tablet conducted under fasting conditions in healthy male and female volunteers
Scientific title A single-dose, single-blinded, balanced, randomised, three-treatment, three-period, three-sequence pilot bioequivalence study of doxycycline delayed release capsules in a 3 way crossover comparison against the innovator doxycycline delayed release tablet conducted under fasting conditions in healthy…
Primary sponsor Zenith Technology Corp Ltd
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1
Countries New Zealand
Conditions Pilot bioequivalence study conducted in healthy volunteers comparing three formulations of doxycycline with no health condition or problem studied. Although this study is being conducted in healthy volunteers who are not being treated for…
Interventions Single dose, crossover study design whereby each participant receives the test formulation of doxcycline (1 x 90 mg (Test 1) on one occasion and 1 x 90 mg (Test 2) on one occasion) and the innovator formulation of doxycycline (1 x 75 mg )…
Registration date Mar 13, 2014
Target size 12
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations